reckitt benckiser group plc - RBGLY

RBGLY

Close Chg Chg %
12.15 -0.13 -1.07%

Open Market

12.02

-0.13 (1.07%)

Volume: 2.60K

Last Updated:

Nov 21, 2024, 9:34 AM EDT

Company Overview: reckitt benckiser group plc - RBGLY

RBGLY Key Data

Open

$12.02

Day Range

12.02 - 12.02

52 Week Range

10.24 - 15.03

Market Cap

$41.44B

Shares Outstanding

3.44B

Public Float

N/A

Beta

0.41

Rev. Per Employee

N/A

P/E Ratio

21.94

EPS

$0.77

Yield

383.75%

Dividend

$0.19

EX-DIVIDEND DATE

Aug 5, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

1.64M

 

RBGLY Performance

1 Week
 
0.91%
 
1 Month
 
-3.19%
 
3 Months
 
6.11%
 
1 Year
 
-10.66%
 
5 Years
 
-21.81%
 

RBGLY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 16
Full Ratings ➔

About reckitt benckiser group plc - RBGLY

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Johann A. Benckiser in 1823 and is headquartered in Slough, the United Kingdom.

RBGLY At a Glance

Reckitt Benckiser Group Plc
Turner House
Slough, Berkshire SL1 3UH
Phone 44-1753-217800 Revenue 18.16B
Industry Household/Personal Care Net Income 2.03B
Sector Consumer Non-Durables 2023 Sales Growth 1.99%
Fiscal Year-end 12 / 2024 Employees 53,035
View SEC Filings

RBGLY Valuation

P/E Current 21.94
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 24.381
Price to Sales Ratio 2.733
Price to Book Ratio 4.581
Price to Cash Flow Ratio 15.146
Enterprise Value to EBITDA 12.475
Enterprise Value to Sales 3.237
Total Debt to Enterprise Value 0.185

RBGLY Efficiency

Revenue/Employee 342,363.689
Income Per Employee 38,298.232
Receivables Turnover 6.649
Total Asset Turnover 0.525

RBGLY Liquidity

Current Ratio 0.636
Quick Ratio 0.44
Cash Ratio 0.166

RBGLY Profitability

Gross Margin 59.786
Operating Margin 22.729
Pretax Margin 16.437
Net Margin 11.186
Return on Assets 5.873
Return on Equity 18.358
Return on Total Capital 9.381
Return on Invested Capital 10.288

RBGLY Capital Structure

Total Debt to Total Equity 101.054
Total Debt to Total Capital 50.262
Total Debt to Total Assets 31.46
Long-Term Debt to Equity 81.179
Long-Term Debt to Total Capital 40.377
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Reckitt Benckiser Group Plc - RBGLY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
17.94B 18.20B 17.80B 18.16B
Sales Growth
+9.49% +1.43% -2.19% +1.99%
Cost of Goods Sold (COGS) incl D&A
7.23B 7.73B 7.54B 7.30B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
602.71M 590.01M 744.00M 584.23M
Depreciation
419.33M 408.47M 405.26M 451.23M
Amortization of Intangibles
183.38M 181.54M 338.74M 133.01M
COGS Growth
+10.06% +6.89% -2.37% -3.22%
Gross Income
10.71B 10.47B 10.26B 10.86B
Gross Income Growth
+9.11% -2.25% -2.05% +5.82%
Gross Profit Margin
+59.71% +57.54% +57.62% +59.79%
2020 2021 2022 2023 5-year trend
SG&A Expense
6.58B 6.64B 6.11B 6.73B
Research & Development
369.32M 430.47M 400.33M 418.91M
Other SG&A
6.21B 6.21B 5.71B 6.31B
SGA Growth
+16.91% +1.02% -8.01% +10.09%
Other Operating Expense
- - - -
-
Unusual Expense
1.37B (977.84M) 167.52M 1.02B
EBIT after Unusual Expense
2.76B 4.81B 3.98B 3.10B
Non Operating Income/Expense
61.55M (4.80B) 130.57M 275.96M
Non-Operating Interest Income
78.22M 41.26M 68.98M 63.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
420.61M 363.08M 328.89M 395.29M
Interest Expense Growth
-5.53% -13.68% -9.42% +20.19%
Gross Interest Expense
420.61M 363.08M 328.89M 395.29M
Interest Capitalized
- - - -
-
Pretax Income
2.40B (353.45M) 3.78B 2.98B
Pretax Income Growth
+189.40% -114.71% +1,169.54% -21.05%
Pretax Margin
+13.39% -1.94% +21.23% +16.44%
Income Tax
923.30M (286.06M) 875.80M 936.02M
Income Tax - Current - Domestic
109.00M 75.64M 155.20M 78.31M
Income Tax - Current - Foreign
782.24M 975.09M 760.01M 922.34M
Income Tax - Deferred - Domestic
32.06M (1.34B) (39.42M) (64.64M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.48B (71.52M) 2.90B 2.05B
Minority Interest Expense
20.52M 15.13M 23.40M 17.40M
Net Income
1.46B (86.64M) 2.88B 2.03B
Net Income Growth
+141.04% -105.94% +3,422.41% -29.44%
Net Margin Growth
+8.13% -0.48% +16.17% +11.19%
Extraordinaries & Discontinued Operations
- - 64.12M 42.63M
-
Discontinued Operations
- - 64.12M 42.63M
-
Net Income After Extraordinaries
1.52B (44.01M) 2.88B 2.03B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.52B (44.01M) 2.88B 2.03B
EPS (Basic)
0.4282 -0.0123 0.8049 0.5668
EPS (Basic) Growth
+132.29% -102.87% +6,643.90% -29.58%
Basic Shares Outstanding
3.55B 3.57B 3.58B 3.58B
EPS (Diluted)
0.4265 -0.0123 0.8024 0.5656
EPS (Diluted) Growth
+132.16% -102.88% +6,623.58% -29.51%
Diluted Shares Outstanding
3.57B 3.57B 3.59B 3.59B
EBITDA
4.74B 4.42B 4.89B 4.71B
EBITDA Growth
-0.21% -6.77% +10.67% -3.66%
EBITDA Margin
+26.41% +24.28% +27.47% +25.95%

Reckitt Benckiser Group Plc in the News